Documents attached to bibliography entries

CMA policy makes no mention of disability resulting from immunization shots. Also, they publish a policy about immunization during a period where they were declaring, in relation to environmental sensitivities, they do not make statements about specific aspects of health care. A similar policy summary concerning sensitivities might have saved many thousands of lives.

Section 32(2)(b) This provision is contrary to the traditional medical dictum of Ilfirst do no harm". The most likely cause of delay on the part of the department will be administrative inefficiency or extra concern regarding the substance in q~estion. It would therefore be much more appropriate to create a system that would keep the potentially-offending substance out until a decision was actually made. As physicians, we shudder at the thought that such a system could prevail for the marketing of pharmaceutical products: that is, the manufacturer would be allowed to sell a product unless the Health Protection Branch objected within a stated period of time following application.